Introduction
Preeclampsia (PE) is one of the most common and serious complications of pregnancy. There is persuasive evidence that genetic factors are implicated in the genesis of PE (1) . However, there are several genetic association studies that have shown both positive (2-4) and negative (5, 6) associations with PE. At the present time, therefore, very few genes with a potential causative role for PE have been identified.
Steroid hormones regulate a wide range of cellular events by activating a receptor family of transcription factors. Estrogens, a kind of steroid hormone, affect the systemic brain, heart (7), liver, and cardiovascular systems (8, 9) . Estrogen's action in the target tissues occurs via the activation of one or both of the two estrogen receptors, ERα (ESR1) and ERβ (ESR2), which are members of the nuclear receptor superfamily (10, 11) . The conventional estrogen receptor, ESR1, is expressed mainly in the prostate gland or the ovary (12) , while ESR2 is widely expressed in many tissues that include not only the prostate and ovary but also the bladder, lung, uterus, brain and cardiovascular systems (13) . ESR1 and ESR2 are also both expressed in vascular endothelial and smooth muscle cells, and in myocardial cells (12) .
Estrogen receptors have been studied intensely within the field of female reproductive physiology. Recently, the function of estrogen receptors has been estimated for both genders, especially with regard to cardiovascular diseases. Accumulating evidence derived from clinical, epidemiological, and experimental studies suggest that an estrogen deficiency plays a major role in the pathogenesis of cardiovascular diseases such as hypertension in postmenopausal women (14, 15) . Estrogen receptors are necessary and sufficient for estrogen-mediated protection against vascular injury (16, 17) . Furthermore, in 2002 it was reported that the ESR2-deficient knockout mouse exhibited hypertension that resulted from a change in blood vessel contraction (18) .
The aim of the present study was to investigate the relationships between single nucleotide polymorphisms (SNPs) in the human ESR2 gene and PE in Japanese subjects, and to assess the involvement of a family history of hypertension in PE via a case-control study.
Methods

Subjects
The study group consisted of 84 Japanese women with PE with a median age of 31 years (ranging from 17 to 45 years) and a total of 160 non-PE Japanese women with a median age of 30 years (ranging from 17 to 41 years). The subjects in both groups lived in the Kanto district in Japan and were recruited from patients and healthy volunteers visiting the Nihon University Hospital in Tokyo. Informed consent was obtained from each individual as per a protocol approved by the Human Studies Committee of Nihon University.
PE was defined as an elevation of blood pressure plus proteinuria. The blood pressure criteria consisted of a mean blood pressure on repeated prelabor measurements of greater than 140 mmHg systolic blood pressure (SBP) and/or greater than 90 mmHg diastolic blood pressure (DBP). The blood pressures used were the maximal values recorded during the patient evaluations. We ascertained that all PE patients were normotensive before 20 weeks of gestation, and also that all PE patients had blood pressures that returned to normal in the puerperium. Non-PE was defined as the absence of PE throughout the duration of the pregnancy. The subjects in both groups were followed throughout the duration of their pregnancies, and all of the diagnoses and examinations were performed at our hospital.
The proteinuria criteria were a value greater than 1 on a catheterized, greater than 2 on a voided, and greater than 300 mg on a 24-h urine specimen, or a protein/creatinine ratio of 0.3. The same elevations in blood pressure in the absence of proteinuria were used to define transient hypertension of pregnancy. Body mass index (BMI) during pregnancy meant BMI at the delivery. The PE group and the non-PE group were further divided into two subgroups based on the presence or absence of a family history of hypertension, which was defined as prior diagnosis of hypertension in grandparents, uncles, aunts, parents or siblings (Table 1) .
Genotyping
Based on the information on the National Center of Biotechnology Information (NCBI) database web site or from the Celera Discovery System (CDS), the SNPs that had a minor allele frequency greater than 30% were chosen. We selected four SNPs in the human ESR2 gene for determination of the genetic association study between PE and non-PEs. One was located in the intron and one was located in the 3 untranslated region of the ESR2 gene. The two remaining SNPs were in the intergenic region between the ESR and spectrin repeat containing, nuclear envelope 2 (SYNE2) genes ( Fig. 1 ). Blood samples were collected from all participants, and genomic DNA was extracted from the peripheral blood mononuclear cells by standard procedures (19) . Each genotyping was performed using an Assays-on-Demand ® kit commercially supplied by Applied Biosystems (Branchburg, USA). The Assays-on-Demand ® kit was applied using the TaqMan ® polymerase chain reaction (PCR) method. In the 5 nuclease assay, discrimination occurs during the PCR because of allele-specific fluorogenic probes that, when hybridized to the template, are cleaved by the 5 nuclease activity of Taq polymerase. The probes contain a 3 minor groove binding group (MGB) that hybridizes to single-stranded targets with increased sequence-specificity compared to ordinary DNA probes. This reduces non-specific probe hybridization and results in low background fluorescence during the 5 nuclease PCR assay (TaqMan ® ; Applied Biosystems). Cleavage results in increased emission of a reporter dye. Each 5 nuclease assay requires two unlabeled PCR primers and two allele-specific probes. Each probe is dually labeled with a reporter dye at the 5 end. VIC ® and 6-carboxyfluorescein (FAM) were used as the reporter dyes. Each primer and probe set was set in the Assays-on-Demand ® SNP Genotyping system (Applied Biosystems) as per the information on the Applied Biosystems web site (http:// abassays.celera.com/cdsEntry/Marketing/snp_overview.jsp).
PCR was accomplished by using 12.5 µl of TaqMan Universal Master Mix No AmpErase ® UNG (2 ) (Applied Biosystems) in 25 µl final volume reactions, with 2 ng DNA, 0.625 µl Assays-on-Demand ® SNP Genotyping Assay Mix (20 ) , 900 nmol/l primers, and 250 nmol/l final concentrations of the probes. Thermal cycling conditions were 50 ºC for 2 min, 95 ºC for 10 min, and then 40 cycles of 95 ºC for 15 s and 62 ºC for 1 min. Thermal cycling was performed on GeneAmp 9700 systems.
Each 96-well plate contained 80 samples of an unknown genotype, eight known allele 1 homozygotes, eight known allele 2 homozygotes, and eight reactions with reagents but no DNA (no template control). The homozygote and no-DNA-control samples were necessary for the SDS 7700 signal processing as outlined in the TaqMan Allelic Discrimination Guide (Applied Biosystems). Direct sequencing, singlestrand conformation polymorphism (SSCP), or denaturing high pressure liquid chromatography was used to confirm control sample genotypes. PCR plates were read on the Sequence Detection System (SDS) 7700 instrument with the end-point analysis mode of the SDS v1.6.3 software package (Applied Biosystems). Genotypes were determined visually based on the dye-component fluorescent emission data depicted in the X-Y scatter-plot of the SDS software (20) . Genotypes were also determined automatically by the signal processing algorithms in the software. Results of each scoring method were saved in two separate output files for later comparison.
Statistical Analysis
Data are presented as the mean SD. Hardy-Weinberg equilibrium was assessed by χ 2 analysis. The overall distribution of alleles was analyzed by 2 2 contingency tables, and the distributions of the genotypes between PE patients and non-PE subjects were tested using a 2-sided Fisher exact test and multiple logistic regression analysis (21) . PE was regarded as the dependent variable while genotypes and age were considered as the independent variables. The statistical significance was established at the p<0.05 level.
Results
The clinical characteristics of the PE patients and non-PE subjects are shown in Table 1 . Non-pregnancy and pregnancy BMI, SBP, and DBP were significantly higher in the PE group than in the non-PE group. The gestational weeks at pregnancy, birth weight of neonates, and Apgar score were significantly lower in the PE group than in the non-PE group. The frequency of family history of hypertension was significantly higher in the PE than in the non-PE group. No significant differences in age, the frequency of primigravidas or the gain of body weight during the pregnancy period were observed between the PE and non-PE groups.
We performed an association study using four SNPs. No significant differences in the overall distribution of rs1256030, C_11462726_10, rs928554 and rs1048315 were observed between the PE and the non-PE groups.
Furthermore, we analyzed the data by dividing both the PE and non-PE subjects into two subgroups that were separated on the basis of the presence or absence of a family history of hypertension (Table 2 ). For the analysis of the fre-
Fig. 1. Organization of the human ESR2 gene and location of the SNPs in a case-control study. The gene is approximately 24 kilobase pairs (kbp) in length, and has a total of 9 exons. Vertical lines indicate the exons.
quency of the G allele for rs928554, we found that PE subjects with a family history of hypertension had a significantly lower allelic percentage (28.7%) than that seen for non-PE controls without a family history of hypertension (41.5%) ( p 0.042). Multiple logistic linear regression analysis adjusted for age showed a significant difference in distributions of genotypes between the non-PE and PE groups for the total study population (odds ratio 1.08; 95% confidence interval (CI), 1.17-1.37). The other three SNPs did not exhibit any significant differences in the overall distribution of the genotypes and alleles.
The study participants were divided into groups based on the rs928554 genotypes, and the clinical parameters for each are shown in Table 3 . SBP was significantly lower in the PE patients with the AA genotype than in PE subjects with the AG or GG genotypes.
Discussion
Estrogen receptors are necessary and sufficient for estrogenmediated protection against vascular injury (16, 17) . Recently, Zhu et al. established the mouse disrupted ESR2 gene (18) . They showed that vascular smooth muscle cells and blood vessels from ESR2-deficient mice exhibit multiple functional abnormalities. In the wild-type mouse blood vessels, estrogen attenuates vasoconstriction by an ESR2-mediated increase in inducible nitric oxide synthase expression. In contrast, estrogen augments vasoconstriction in blood vessels from ESR2-deficient mice. Vascular smooth muscle cells isolated from ESR2-deficient mice have been shown to exhibit multiple abnormalities in ion channel function. Furthermore, ESR2-deficient mice develop sustained systolic and diastolic hypertension as they age. These data support an essential role for ESR2 in the regulation of vascular function and blood pressure. An animal model for PE, the spontaneous hypertension and heart failure (SHHF) rat, has been found to simultaneously exhibit spontaneous pregnancy-associated hypertension, small for gestational age (SGA) offspring, and altered placental gene expression (22) . Placentas from SHHF rats display altered expression of several genes that are implicated in PE, including the estrogen receptor regulator. Therefore, based on these previous findings, we sought to determine whether the ESR2 gene was associated with PE. The pathophysiology of PE remains uncertain despite many research efforts and actual hypotheses that have been put forth to explain the vascular damage that characterizes the disease. Among the many factors influencing vascular reactivity, those that could possibly be implicated in the disease mechanism include the renin-angiotensin system, prostaglandins, progesterone and its metabolites, calcium, magnesium, digoxin-like immunoreactive substance(s), auricular natriuretic factor, substances secreted by platelets and leukotrienes (23) . As these factors are involved in vascular function or blood pressure, it is thought that the pathophysiology of PE overlaps with that of hypertension. Some investigators have reported that a family history of hypertension is indicative of a statistically significant increased risk of PE (24, 25) . Qui et al. (24) gathered information on the first-degree family history of hypertension during postpartum interviews. As compared with women with no parental history of hypertension, women with maternal only (odds ratio 1.9), paternal only (odds ratio 1.8), or both maternal and paternal history of hypertension (odds ratio 2.6) had a statistically significant increased risk of PE. The odds ratio for women with at least one hypertensive parent and a hypertensive sibling was 4.7 (95% CI, 1.9-11.6). These results are consistent with the thesis that a family history of hypertension reflects genetic and behavioral factors, and thus that women with such histories may be predisposed to have an increased risk of PE.
Furthermore, PE has been thought to be a multifactorial genetic disorder. Several candidate genes for this disease had been investigated by studies using polymorphic genetic markers. Some studies have reported associations of PE with genes such as the methylenetetrahydrofolate reductase gene (2), plasminogen activator inhibitor type-1 (PAI-1) gene (3), and the angiotensin-converting enzyme gene (4). In contrast, other studies have failed to show any association with genes such as the β3-adrenergic receptor gene (5) , and the estrogen receptor α gene (6) . In association analyses that use a genetic marker, not only the selection of subjects but also the verification of positive data are very important and can be the source of problems. Therefore, the discrepant results that have been reported may be attributed not only to the different criteria used in the selection of subjects, but also to the racial differences seen in the populations studied. In the present experiment we found no significant differences in the overall distribution of the four SNPs between the PE and non-PE groups when the presence or absence of a family history of hypertension was not considered during the analysis. Whereas, when the frequencies of the alleles in rs928554 were analyzed with respect to the presence or absence of a family history of hypertension between the subgroups of the PE and non-PE groups, the overall distribution of alleles showed a significant difference between the two groups. These results are consistent with the previous report by Qui et al. (24) . Until now, there have been no studies that have analyzed the association between a candidate gene and PE that were divided into subgroups according to the presence or absence of a family history of hypertension. Thus, the analytical method of the present study could be very beneficial in helping to define further research studies in this area. Furthermore, there were significant differences for the level of SBP when examined between PE groups that were divided based on the genotypes. It is thought that rs928554 is a genetic marker and not a functional SNP because it is located in the intron. However, our results may reflect that the genetic differences observed for ESR2 or the neighboring genes that are linked to the A allele of rs928554 could influence the pathophysiology of PE. This is supported by our finding that blood pressure levels for PE associated with the AA genotype were relatively lower than those for PE not associated with the AA genotype.
In conclusion, we have shown a significant difference for the allele frequencies of one SNP that was observed among the subgroups of PE subjects that were divided on the basis of the presence or absence of a family history of hypertension. Although it is possible that the results were led by any chance because the sample numbers were small, our findings suggest that the genetic backgrounds of PE and hypertension are may be similar.
